Elixher Uncategorized INVO Fertility, Inc. Reports Q1 2025 Financial Results and Strategic Focus on Core … – Nasdaq

INVO Fertility, Inc. Reports Q1 2025 Financial Results and Strategic Focus on Core … – Nasdaq

INVO Fertility reported Q1 2025 revenue growth but significant net losses, primarily due to impairment charges related to NAYA Therapeutics.

Related Post